...
首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese.
【24h】

Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese.

机译:GSTM1和CYP2D6基因的多态性与中国肺癌的易感性相关。

获取原文
获取原文并翻译 | 示例
           

摘要

The case-control study was conducted to examine the association between GSTM1 null and CYP2D6Ch (T(188)/T) genotypes and lung cancer risk among Chinese of Han nationality living in Guangdong. All 191 subjects were investigated with unitary questionnaire and their DNAs were isolated from peripheral lymphocytes by standard procedures with proteinase K digestion and phenol/chloroform extraction. GSTM1(-) was detected with polymerase chain reaction (PCR) in all 191 subjects, involving 59 lung cancer cases, 59 hospital controls and 73 healthy controls. The frequencies of GSTM1(-) were not significantly different between the cases and the two controls overall. However, among adenocarcinoma of lung, the frequency of GSTM1(-) (76.9%) appeared to be higher than that in controls (49.2%), and the odd radios were 3.42-3.45. The results suggested an elevated risk for adenocarcinoma of lung would be shown by GSTM1(-). Using polymerase chain reaction-restriction fragment length polymorphisms (PCR-RFLP) to detect CYP2D6 T(188)/T genotype in 59 lung cancer patients and 59 hospital controls, it showed no significant difference between the two groups. However, non-smokers with non-T(188)/T (C(188)/C or C(188)/T) genotype showed 3.78-folds increased risk of lung cancer compared with those with T(188)/T genotype (P=0.036). The data did not suggest a substantial interaction effect between GSTM1 and CYP2D6 polymorphisms and the risk of lung cancer. Additionally, among Chinese (Han) of Guangdong, the frequency of CYP2D6 T(188) allele appeared to be 57.2%, and GSTM1(-) to be 51.8%.
机译:病例对照研究旨在探讨广东省汉族人群中GSTM1 null和CYP2D6Ch(T(188)/ T)基因型与肺癌风险之间的关系。通过统一问卷调查对所有191名受试者进行调查,并通过蛋白酶K消化和苯酚/氯仿提取的标准程序从外周淋巴细胞中分离其DNA。通过聚合酶链反应(PCR)在所有191位受试者中检测到GSTM1(-),涉及59例肺癌病例,59例医院对照和73例健康对照。 GSTM1(-)的频率在病例与两个对照组之间没有显着差异。然而,在肺腺癌中,GSTM1(-)的频率(76.9%)似乎高于对照组(49.2%),奇数无线电波为3.42-3.45。结果表明,GSTM1(-)显示出肺腺癌的风险升高。使用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)检测CYP2D6 T(188)/ T基因型在59例肺癌患者和59例医院对照组中,两组之间无显着差异。然而,非T(188)/ T(C(188)/ C或C(188)/ T)基因型的非吸烟者与T(188)/ T基因型的人相比,患肺癌的风险增加了3.78倍(P = 0.036)。数据未显示GSTM1和CYP2D6多态性与肺癌风险之间存在实质性相互作用。此外,在广东的汉族人群中,CYP2D6 T(188)等位基因的频率似乎为57.2%,而GSTM1(-)为51.8%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号